Loading...
OTCMEMGE
Market cap33kUSD
Dec 24, Last price  
0.00USD
1D
0.00%
1Q
-38.46%
Jan 2017
-99.06%
IPO
-92.00%
Name

Emergent Health Corp

Chart & Performance

D1W1MN
OTCM:EMGE chart
P/E
P/S
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
74.65%
Rev. gr., 5y
10.56%
Revenues
2m
+184.54%
0989,835183,120167,191119,567574,6131,635,026
Net income
-2m
L-22.75%
0121,027-67,498-79,125-288,764-2,107,450-1,628,073
CFO
-1m
L-35.67%
076,971-54,239-57,251-161,628-1,896,079-1,219,802

Profile

Emergent Health Corp. develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. Its products comprise Vita-Stim, a nutrient that enhances the immune system, nourishes stem cells, and maintains health; Neuvitale, which nourishes stem cells and acts as a methyl donor to protect DNA; Hungarest, a diet aid that controls appetite in the brain and stomach; EmergentO2, water oxygenator, which increases oxygen in the blood stream; and products for reducing facial wrinkles. The company distributes its products through health food stores, pharmacies, and various other retail outlets throughout the United States and internationally. Emergent Health Corp. is based in King of Prussia, Pennsylvania. As of August 26, 2014, Emergent Health Corp was taken private.
IPO date
Dec 28, 2007
Employees
6
Domiciled in
US
Incorporated in
US

Valuation

Title
in thousands, except ratios and share amounts
FYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT